OpenVSafe by OpenVAERS
Search V-safe

ZTX-90345-70631

2 vaccinations 9 coded responses 23 check-ins 9 free-text entries 0 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
981 / WA
Registered
2021-02-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-19
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-21
    Registered in v-safe
  3. 2021-02-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-02-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-02-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-02-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-25
    Survey response — days 1–6 daily, dose 1
    MedDRA: Abnormal dreams — Feeling: Good
    Free text: Some pretty extreme dreaming activity, not sure if related to vaccine, or not.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-28
    Survey response — day 7, dose 1
    MedDRA: Abnormal dreams — Feeling: Good
    Free text: Continued intense dreaming while sleeping. Not sure if its related to vaccine.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-03-05
    Survey response — day 14, dose 1
    MedDRA: Fatigue — Feeling: Good
    Free text: Fatigue (only).
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-03-12
    Dose 2 — Pfizer-BioNTech
  11. 2021-03-12
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-03-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site pain — Feeling: Good
    Free text: Slight soreness around injection pint of entry, 1 or 2 on a scale of 1-10 with 10 being the worst.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-03-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-03-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  15. 2021-03-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  16. 2021-03-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  17. 2021-03-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  18. 2021-03-19
    Health check-in — day 7, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  19. 2021-03-26
    Survey response — day 14, dose 2
    MedDRA: Abnormal dreams, Fatigue — Feeling: Good
    Free text: Low-grade fatigue and intense dream activity continues, though not a new or worsening symptom.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-04-02
    Survey response — day 21, dose 2
    MedDRA: Abnormal dreams, Fatigue — Feeling: Good
    Free text: Continuing fatigue and heightened dream activity.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-04-10
    Survey response — day 28, dose 2
    MedDRA: Abnormal dreams, Fatigue — Feeling: Good
    Free text: Continued fatigue and intensified dream activity.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-04-16
    Survey response — day 35, dose 2
    MedDRA: Abnormal dreams, Fatigue — Feeling: Good
    Free text: Low-grade fatigue and intensified dream activity continues. Not sue if vaccine-related, or not.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-04-23
    Survey response — day 42, dose 2
    MedDRA: Abnormal dreams, Fatigue — Feeling: Good
    Free text: Continuing low-grade fatigue and intensified dream activity
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-06-11
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-09-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2022-03-14
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-19Pfizer-BioNTech
22021-03-12Pfizer-BioNTech

Free text

Release 4 — days 1–6 daily, dose 1

2021-02-25

Systemic reaction (other): Some pretty extreme dreaming activity, not sure if related to vaccine, or not.

Release 4 — day 7, dose 1

2021-02-28

Systemic reaction (other): Continued intense dreaming while sleeping. Not sure if its related to vaccine.

Release 5 — day 14, dose 1

2021-03-05

Symptoms: Fatigue (only).

Release 5 — days 1–6 daily, dose 2

2021-03-13

Systemic reaction (other): Slight soreness around injection pint of entry, 1 or 2 on a scale of 1-10 with 10 being the worst.

Release 6 — day 14, dose 2

2021-03-26

Symptoms: Low-grade fatigue and intense dream activity continues, though not a new or worsening symptom.

Release 6 — day 21, dose 2

2021-04-02

Symptoms: Continuing fatigue and heightened dream activity.

Release 7 — day 28, dose 2

2021-04-10

Symptoms: Continued fatigue and intensified dream activity.

Release 7 — day 35, dose 2

2021-04-16

Symptoms: Low-grade fatigue and intensified dream activity continues. Not sue if vaccine-related, or not.

Release 7 — day 42, dose 2

2021-04-23

Symptoms: Continuing low-grade fatigue and intensified dream activity

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbnormal dreams ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SROAbnormal dreams ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release